Literature DB >> 28379600

Hepatotoxicity associated to synthetic cannabinoids use.

R Solimini1, F P Busardò, M C Rotolo, S Ricci, L Mastrobattista, C Mortali, S Graziano, M Pellegrini, N M di Luca, I Palmi.   

Abstract

Synthetic cannabinoids (SCs) are psychotropic compounds, chemically created in laboratory to mimic cannabinergic brain activity of delta-9 tetrahydrocannabinol. The consumption of these compounds for recreational purposes can lead to a variety of adverse effects on health including overdose and deaths. Increasingly popular as substances of abuse since the 2000s, SCs were produced initially to bind and study cannabinoid receptors (they also can be called synthetic cannabimimetics) failing in eliminating the psychoactive effects. Currently, SCs are misused by students and young adults as "natural products" because of their herbal aspect. Actually, these apparently innocuous recreational substances hide toxic effects to health. Reported side effects are cardiovascular, gastrointestinal, neurological, renal, metabolic, ophthalmologic, pulmonary and psychoactive including dependence and withdrawal. A few cases of SCs ingestion have also been associated with liver failure. We herein review the recent literature on the SCs toxicity with particular attention to liver damage aspects.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28379600

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  7 in total

1.  Highly sensitive screening and analytical characterization of synthetic cannabinoids in nine different herbal mixtures.

Authors:  Vera L Alves; João L Gonçalves; Joselin Aguiar; Maria J Caldeira; Helena M Teixeira; José S Câmara
Journal:  Anal Bioanal Chem       Date:  2021-02-11       Impact factor: 4.142

2.  Metabolites of Synthetic Cannabinoid 5F-MDMB-PINACA Retain Affinity, Act as High Efficacy Agonists and Exhibit Atypical Pharmacodynamic Properties at CB1 Receptors.

Authors:  Christian V Cabanlong; Lauren N Russell; William E Fantegrossi; Paul L Prather
Journal:  Toxicol Sci       Date:  2022-04-26       Impact factor: 4.109

3.  Post-Mortem Toxicology: A Systematic Review of Death Cases Involving Synthetic Cannabinoid Receptor Agonists.

Authors:  Arianna Giorgetti; Francesco Paolo Busardò; Roberta Tittarelli; Volker Auwärter; Raffaele Giorgetti
Journal:  Front Psychiatry       Date:  2020-05-25       Impact factor: 4.157

4.  UHPLC-HRMS and GC-MS Screening of a Selection of Synthetic Cannabinoids and Metabolites in Urine of Consumers.

Authors:  Manuela Pellegrini; Emilia Marchei; Esther Papaseit; Magí Farré; Simona Zaami
Journal:  Medicina (Kaunas)       Date:  2020-08-13       Impact factor: 2.430

5.  Determination of the Synthetic Cannabinoids JWH-122, JWH-210, UR-144 in Oral Fluid of Consumers by GC-MS and Quantification of Parent Compounds and Metabolites by UHPLC-MS/MS.

Authors:  Nunzia La Maida; Manuela Pellegrini; Esther Papaseit; Clara Pérez-Mañá; Lourdes Poyatos; Mireia Ventura; Liliana Galindo; Francesco Paolo Busardò; Simona Pichini; Magí Farré; Emilia Marchei
Journal:  Int J Mol Sci       Date:  2020-12-10       Impact factor: 5.923

Review 6.  Marijuana: A systems-based primer of adverse effects associated with use and an overview of its therapeutic utility.

Authors:  Asim Kichloo; Michael Albosta; Michael Aljadah; Zain El-Amir; Ghazaleh Goldar; Muhammed Zatmar Khan; Dushyant Singh Dahiya; Srilakshmi Vallabhaneni; Farah Wani; Jagmeet Singh
Journal:  SAGE Open Med       Date:  2021-03-09

7.  Cytotoxicity, metabolism, and isozyme mapping of the synthetic cannabinoids JWH-200, A-796260, and 5F-EMB-PINACA studied by means of in vitro systems.

Authors:  Tanja M Gampfer; Lea Wagmann; Anouar Belkacemi; Veit Flockerzi; Markus R Meyer
Journal:  Arch Toxicol       Date:  2021-08-28       Impact factor: 5.153

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.